FibroBiologics, Inc. Common Stock (FBLG) — Financial Flexibility Index
FibroBiologics, Inc. Common Stock (FBLG) has a Financial Flexibility Index of -0.46x as of September 2025. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $6.00K) represents 0% of total liabilities ($8.62 Million). Also explore FibroBiologics, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
FibroBiologics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for FibroBiologics, Inc. Common Stock across 4 annual periods. See net asset quality index of FibroBiologics, Inc. Common Stock to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for FibroBiologics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for FibroBiologics, Inc. Common Stock. For the full company profile including market capitalisation, see how much is FibroBiologics, Inc. Common Stock worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.85x | $-11.72 Million | $-11.90 Million | $13.71 Million | ▼ -52.9% |
| 2024 | -0.56x | $-5.91 Million | $-6.40 Million | $10.57 Million | ▼ -21.2% |
| 2023 | -0.46x | $-4.07 Million | $-4.07 Million | $8.82 Million | ▲ +42.5% |
| 2022 | -0.80x | $-1.41 Million | $-1.41 Million | $1.76 Million | — |